30 fim coated tablets , 25mg Empagliflozin , is a sodium-glucose co-transporter 2 (SGLT2) inhibitor 

indicated:-is indicated for the treatment of adults with insufficiently controlled type 2

diabetes mellitus as an adjunct to diet and exercise.In patients tolerating empagliflozin 10 mg once daily who have an eGFR >60

ml/min/1.73 m2 and need tighter glycaemic control, the dose can be increased to 25 mg

once daily